Sera from patients with SPS but not T1D generally react strongly by immunoblotting and inhibit GAD enzyme activity [27], [28], and interestingly, anti-GAD reactivity by immunoblotting in SPS-sera is with GAD65 but not GAD67 [28]. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.